$XBP
XBP Europe Holdings Inc Stock $xbp

$xbp Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000121390023067004 Filed on August 14, 2023

Income Statement

Concept	2023 Q2
Revenue	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit	$11.69M
YoY Change
Gross Profit Margin
Selling, General & Admin	$530.0K
YoY Change	3.31%
% of Gross Profit	4.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$946.0K
YoY Change
% of Gross Profit	8.09%
Operating Expenses	$530.0K
YoY Change	3.31%
Operating Profit	-$525.5K
YoY Change	2.45%
Interest Expense	$0.00
YoY Change	-100.0%
% of Operating Profit
Other Income/Expense, Net	$350.0K
YoY Change	-18.43%
Pretax Income	-$360.0K
YoY Change	-135.8%
Income Tax	$25.68K
% Of Pretax Income
Net Earnings	-$386.1K
YoY Change	-139.99%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.03
Diluted Earnings Per Share	-$0.05
COMMON SHARES
Basic Shares Outstanding	21.80M
Diluted Shares Outstanding	21.80M

Balance Sheet

Concept	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$0.00
YoY Change	-100.0%
Cash & Equivalents	$25.00K
Short-Term Investments
Other Short-Term Assets	$200.0K
YoY Change	-29.65%
Inventory
Prepaid Expenses	$220.5K
Receivables
Other Receivables
Total Short-Term Assets	$245.5K
YoY Change	-86.04%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$15.70M
YoY Change	-93.04%
Other Assets
YoY Change
Total Long-Term Assets	$15.71M
YoY Change	-93.04%
TOTAL ASSETS
Total Short-Term Assets	$245.5K
Total Long-Term Assets	$15.71M
Total Assets	$15.95M
YoY Change	-92.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$1.364M
YoY Change	685.4%
Deferred Revenue
YoY Change
Short-Term Debt	$9.500M
YoY Change	37.64%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$10.91M
YoY Change	27.47%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change
Other Long-Term Liabilities	$3.500M
YoY Change	17.47%
Total Long-Term Liabilities	$3.500M
YoY Change	17.47%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.91M
Total Long-Term Liabilities	$3.500M
Total Liabilities	$14.42M
YoY Change	24.96%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.29M
YoY Change	52.84%
Common Stock	$554.00
YoY Change	925.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$13.99M
YoY Change
Total Liabilities & Shareholders Equity	$15.95M
YoY Change	-92.99%

Cashflow Statement

Concept	2023 Q2
OPERATING ACTIVITIES
Net Income	-$386.1K
YoY Change	-139.99%
Depreciation, Depletion And Amortization	$946.0K
YoY Change
Cash From Operating Activities	$0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change
Cash From Investing Activities	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000
YoY Change	-100.0%
NET CHANGE
Cash From Operating Activities	0.000
Cash From Investing Activities	0.000
Cash From Financing Activities	0.000
Net Change In Cash	0.000
YoY Change	-100.0%
FREE CASH FLOW
Cash From Operating Activities	$0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	cffe	Interest Expense Mandatorily Redeemable Securities InterestExpenseMandatorilyRedeemableSecurities		usd
CY2022Q2	us-gaap	Other Income OtherIncome		usd
CY2023Q2	cffe	Interest Expense Mandatorily Redeemable Securities InterestExpenseMandatorilyRedeemableSecurities		usd
CY2023Q2	us-gaap	Other Income OtherIncome		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	cffe	Aggregate Converted Basis Percentage AggregateConvertedBasisPercentage	0.20	pure
	dei	Entity Registrant Name EntityRegistrantName	CF ACQUISITION CORP. VIII
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity File Number EntityFileNumber	001-40206
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2002883
	dei	Entity Address Address Line1 EntityAddressAddressLine1	110 East 59th Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
	dei	City Area Code CityAreaCode	(212)
	dei	Local Phone Number LocalPhoneNumber	938-5000
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	us-gaap	Cash Cash	25000	usd
CY2022Q4	us-gaap	Cash Cash	41154	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	220489	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	210241	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	245489	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	251395	usd
CY2023Q2	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	15707032	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	31445874	usd
CY2023Q2	us-gaap	Assets Assets	15952521	usd
CY2022Q4	us-gaap	Assets Assets	31697269	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1363836	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1189676	usd
CY2023Q2	cffe	Notes Payables Related Parties Classified Current NotesPayablesRelatedPartiesClassifiedCurrent	9490888	usd
CY2022Q4	cffe	Notes Payables Related Parties Classified Current NotesPayablesRelatedPartiesClassifiedCurrent	8200162	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	57517	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	70065	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	10912241	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9459903	usd
CY2023Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	316696	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	178780	usd
CY2023Q2	cffe	Forward Purchase Securities Liability ForwardPurchaseSecuritiesLiability	3191371	usd
CY2022Q4	cffe	Forward Purchase Securities Liability ForwardPurchaseSecuritiesLiability	2504214	usd
CY2023Q2	us-gaap	Liabilities Liabilities	14420308	usd
CY2022Q4	us-gaap	Liabilities Liabilities	12142897	usd
CY2023Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	15523830	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	31169832	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
	cffe	Public Warrants Term PublicWarrantsTerm	P5Y
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	54	usd
CY2023Q2	cffe	Common Stock Value One CommonStockValueOne	125	usd
CY2022Q4	cffe	Common Stock Value One CommonStockValueOne	625	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	298044	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	694592	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14290340	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12310731	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-13991617	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-11615460	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15952521	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31697269	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	438030	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	433001	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	937592	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	804255	usd
CY2023Q2	cffe	Related Party Transaction Selling General And Administrative Expenses From Transaction With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionWithRelatedParty	30000	usd
CY2022Q2	cffe	Related Party Transaction Selling General And Administrative Expenses From Transaction With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionWithRelatedParty	30000	usd
	cffe	Related Party Transaction Selling General And Administrative Expenses From Transaction With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionWithRelatedParty	60000	usd
	cffe	Related Party Transaction Selling General And Administrative Expenses From Transaction With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionWithRelatedParty	60000	usd
CY2023Q2	us-gaap	Taxes Other TaxesOther	57517	usd
CY2022Q2	us-gaap	Taxes Other TaxesOther	50000	usd
	us-gaap	Taxes Other TaxesOther	137517	usd
	us-gaap	Taxes Other TaxesOther	62534	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-525547	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-513001	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1135109	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-926789	usd
CY2023Q2	us-gaap	Interest Income Other InterestIncomeOther	239555	usd
CY2022Q2	us-gaap	Interest Income Other InterestIncomeOther	431970	usd
	us-gaap	Interest Income Other InterestIncomeOther	584364	usd
	us-gaap	Interest Income Other InterestIncomeOther	438410	usd
	cffe	Interest Expense Mandatorily Redeemable Securities InterestExpenseMandatorilyRedeemableSecurities	578107	usd
	us-gaap	Other Income OtherIncome	579294	usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-353091	usd
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-429072	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	137916	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3622210	usd
CY2023Q2	cffe	Change In Fair Value Of Forward Purchase Securities Liability ChangeInFairValueOfForwardPurchaseSecuritiesLiability	427499	usd
CY2022Q2	cffe	Change In Fair Value Of Forward Purchase Securities Liability ChangeInFairValueOfForwardPurchaseSecuritiesLiability	-657626	usd
	cffe	Change In Fair Value Of Forward Purchase Securities Liability ChangeInFairValueOfForwardPurchaseSecuritiesLiability	687157	usd
	cffe	Change In Fair Value Of Forward Purchase Securities Liability ChangeInFairValueOfForwardPurchaseSecuritiesLiability	-704955	usd
CY2023Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-360400	usd
CY2022Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	1005667	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-1953925	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	4418080	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25684	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40231	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25684	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40231	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-386084	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	965436	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1979609	usd
	us-gaap	Net Income Loss NetIncomeLoss	4377849	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-11615460	usd
CY2023Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	242210	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1593525	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-13451195	usd
CY2023Q2	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	154338	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-386084	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-13991617	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-9352134	usd
CY2022Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	4424015	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	49411	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3412413	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-10314325	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	965436	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-329250	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-9678139	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1979609	usd
	us-gaap	Net Income Loss NetIncomeLoss	4377849	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	49411	usd
	cffe	General And Administrative Expenses Paid By Related Party GeneralAndAdministrativeExpensesPaidByRelatedParty	494257	usd
	cffe	General And Administrative Expenses Paid By Related Party GeneralAndAdministrativeExpensesPaidByRelatedParty	1137256	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	584364	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	438410	usd
	us-gaap	Interest Expense Other InterestExpenseOther	578107	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	137916	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3622210	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	687157	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-704955	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-504924	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-541509	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	174160	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1175483	usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-12548	usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-164967	usd
	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	229854	usd
	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	4424015	usd
	cffe	Proceeds From Trust Account To Pay Franchise Taxes ProceedsFromTrustAccountToPayFranchiseTaxes	150115	usd
	cffe	Proceeds From Trust Account To Pay Franchise Taxes ProceedsFromTrustAccountToPayFranchiseTaxes	24113	usd
	cffe	Proceeds From The Trust Account To Redeem Public Shares ProceedsFromTheTrustAccountToRedeemPublicShares	112000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	224056750	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	224056750	usd
	cffe	Proceeds From Trust Account To Redeem Public Shares ProceedsFromTrustAccountToRedeemPublicShares	16228539	usd
	cffe	Proceeds From Trust Account To Redeem Public Shares ProceedsFromTrustAccountToRedeemPublicShares	28799270	usd
	us-gaap	Proceeds From Sale Of Investment Projects ProceedsFromSaleOfInvestmentProjects	62406	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	16323206	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	24399368	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	961015	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	6167502	usd
	cffe	Redemption Paymentfor Public Shares RedemptionPaymentforPublicShares	16290945	usd
	cffe	Redemption Paymentfor Public Shares RedemptionPaymentforPublicShares	28799270	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1009430	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	317873	usd
	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts	62406	usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	62406	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-16339360	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-22949641	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16154	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1449727	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41154	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1474727	usd
	cffe	Prepaid Expenses Paid With Payables To Related Party PrepaidExpensesPaidWithPayablesToRelatedParty	515173	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	112000	usd
CY2023Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	4900000	usd
CY2023Q2	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	400000	usd
	cffe	Redeem Public Share Percentage RedeemPublicSharePercentage	1	pure
CY2022Q3	cffe	Aggregate Amount AggregateAmount	976832	usd
CY2022Q3	cffe	Public Share Per Share PublicSharePerShare	0.33
CY2023Q1	cffe	Aggregate Amount AggregateAmount	344781	usd
CY2023Q1	cffe	Extension Loan ExtensionLoan	57464	usd
CY2023Q1	cffe	Public Share Per Share PublicSharePerShare	0.04
	cffe	Public Share Per Share PublicSharePerShare	10.69
	cffe	Trust Account TrustAccount	16290945	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	41200	usd
CY2023Q2	cffe	Working Capital WorkingCapital	10667000	usd
CY2022Q4	cffe	Working Capital WorkingCapital	9209000	usd
	cffe	Sponsor Exchange SponsorExchange	25000	usd
	us-gaap	Sponsor Fees SponsorFees	79000	usd
CY2023Q2	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	1750000	usd
CY2022Q2	cffe	Working Capital Loan WorkingCapitalLoan	1000000	usd
CY2022Q4	cffe	Working Capital Loan WorkingCapitalLoan	750000	usd
CY2023Q1	cffe	Third Extension Loan ThirdExtensionLoan	344781	usd
CY2023Q1	cffe	Working Capital Loan WorkingCapitalLoan	500000	usd
CY2023Q2	cffe	Face Amounts Loan FaceAmountsLoan	9491000	usd
CY2022Q4	cffe	Face Amounts Loan FaceAmountsLoan	8500000	usd
	us-gaap	Other Expenses OtherExpenses	100000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these unaudited condensed consolidated financial statements is the determination of the fair value of the warrant liability, FPS liability and sponsor loans liability. Such estimates may be subject to change as more current information becomes available and accordingly, the actual results could differ significantly from those estimates.</span></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration of Credit Risk</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal Deposit Insurance Corporation maximum coverage limit of $250,000, and cash equivalents held in the Trust Account. Any loss incurred or lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations and cash flows. For the three and six months ended June 30, 2023 and 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></p>
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q2	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.04	pure
	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.009	pure
CY2021Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	the Company effected a 1.1-for-1 stock split
CY2023Q2	us-gaap	Interest Expense InterestExpense	0	usd
	us-gaap	Interest Expense InterestExpense	248396	usd
CY2023Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	26000	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	26000	usd
CY2023Q2	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	-0.071	pure
	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	-0.013	pure
CY2022Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	40000	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	40000	usd
CY2021Q1	cffe	Issued And Outstanding Shares Percentage IssuedAndOutstandingSharesPercentage	0.20	pure
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29000	usd
CY2021Q1	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	the Company effected a 1.1-for-1 stock split.
CY2021Q1	cffe	Initial Shareholders Holding Percentage InitialShareholdersHoldingPercentage	0.20	pure
CY2023Q2	us-gaap	Shares Outstanding SharesOutstanding	733400	shares
	us-gaap	Other General Expense OtherGeneralExpense	10000	usd
CY2023Q2	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	30000	usd
CY2022Q2	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	30000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	60000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	60000	usd
CY2023Q1	cffe	Working Capital Loan WorkingCapitalLoan	500000	usd
CY2022Q3	cffe	Second Extension Loan SecondExtensionLoan	976832	usd
CY2022Q3	cffe	Public Share Per Share PublicSharePerShare	0.33
CY2023Q1	cffe	Third Extension Loan ThirdExtensionLoan	344781	usd
	cffe	Face Amounts Loans FaceAmountsLoans	9941000	usd
CY2022Q4	cffe	Face Amounts Loans FaceAmountsLoans	8500000	usd
	us-gaap	Debt Instrument Redemption Description DebtInstrumentRedemptionDescription	●in whole and not in part; ● at a price of $0.01 per warrant; ● at any time during the exercise period; ● upon a minimum of 30 days’ prior written notice of redemption; ● if, and only if, the last reported sale price of the Company’s common stock equals or exceeds $18.00 per share for any 20-trading days within a 30-trading day period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders; and ● if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants.
	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	0.01
CY2023Q2	us-gaap	Share Price SharePrice	18
CY2023Q2	cffe	Fps Commitment FPSCommitment	10000000	usd
CY2023Q2	us-gaap	Commitments Fair Value Disclosure CommitmentsFairValueDisclosure	10000000	usd
	cffe	Business Combination BusinessCombination	0.80	pure
CY2022Q4	cffe	Business Combination BusinessCombination	0.80	pure
	cffe	Interest Expense Mandatorily Redeemable Securities InterestExpenseMandatorilyRedeemableSecurities		usd
	us-gaap	Other Income OtherIncome		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Interest Expense Other InterestExpenseOther		usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities		usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities		usd
	us-gaap	Proceeds From Repayments Of Bank Overdrafts ProceedsFromRepaymentsOfBankOverdrafts		usd
	cffe	Prepaid Expenses Paid With Payables To Related Party PrepaidExpensesPaidWithPayablesToRelatedParty		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001839530

Files In Submission

Name	View Source	Status
cffe-20230630_def.xml	Edgar Link	unprocessable
cffe-20230630_lab.xml	Edgar Link	unprocessable
cffe-20230630_pre.xml	Edgar Link	unprocessable
0001213900-23-067004-index-headers.html	Edgar Link	pending
0001213900-23-067004-index.html	Edgar Link	pending
0001213900-23-067004.txt	Edgar Link	pending
0001213900-23-067004-xbrl.zip	Edgar Link	pending
cffe-20230630.xsd	Edgar Link	pending
f10q0623ex31-1_cfacq8.htm	Edgar Link	pending
f10q0623ex31-2_cfacq8.htm	Edgar Link	pending
f10q0623ex32-1_cfacq8.htm	Edgar Link	pending
f10q0623ex32-2_cfacq8.htm	Edgar Link	pending
f10q0623_cfacquisition8.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cffe-20230630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0623_cfacquisition8_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XBP
XBP Europe Holdings Inc Stock $xbp

2023 Q2 Form 10-Q Financial Statement

#000121390023067004 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XBP XBP Europe Holdings Inc Stock $xbp

2023 Q2 Form 10-Q Financial Statement

#000121390023067004 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XBP
XBP Europe Holdings Inc Stock $xbp